CCL3 and myeloid sarcoma: CNS invading Th1 cells and monocytes, as well as CNS resident innate immune cells such as microglia and astrocytes, co-express CCR2 and CCR5, and the ligands CCL2, CCL3, CCL4 and CCL5 are up-regulated in MS lesions.